Our results showed higher CLEC5A expression in IDH1 WT than MUT GBM and depletion of CLEC5A dramatically reduced GBM cell proliferation, invasion, and migration, further confirming its potential oncogenic role in GBM progression. This evidence concerns the gene CLEC5A and glioblastoma.